A Modular Safety System for an Insulin Dose Recommender: A Feasibility Study.
Chengyuan Liu1, Parizad Avari2, Yenny Leal3
1Centre for Bio-Inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, London, UK.
A new safety system for insulin dosing in type 1 diabetes significantly reduced hypoglycemia and improved glycemic control. This intelligent system enhances safety for insulin delivery, benefiting patients with diabetes.
Area of Science:
- Endocrinology
- Biomedical Engineering
- Diabetes Technology
Background:
- Insulin delivery in type 1 diabetes presents significant safety challenges.
- The EU-funded PEPPER project developed an intelligent insulin dose recommender platform.
- Integrating robust safety measures is crucial for insulin dosing systems.
Purpose of the Study:
- To present and clinically evaluate a modular safety system for an intelligent insulin dose recommender.
- To assess the system's impact on glycemic control and safety in type 1 diabetes patients.
- To demonstrate the feasibility of a predictive safety system for insulin therapy.
Main Methods:
- A modular safety system comprising four modules was developed, utilizing a novel glucose forecasting algorithm.
- Modules included predictive glucose alerts, basal insulin suspension for hypoglycemia, carbohydrate recommendations, and personalized safety constraints.
- A pilot study involved eight adults with type 1 diabetes over eight weeks, comparing a run-in period with the safety system's endpoint, using a standard insulin bolus calculator.
Main Results:
- Glycemic control improved significantly over the study period.
- Percentage time in hypoglycemia (<3.0 mmol/l) decreased from 0.82% to 0.33% (P = .02).
- Percentage time in target range (3.9-10.0 mmol/l) increased from 52.8% to 61.3% (P = .03), with fewer carbohydrate recommendations.
Conclusions:
- A safety system integrated with an insulin dose recommender is a viable solution.
- The system effectively reduces adverse events related to glucose control in type 1 diabetes.
- Clinical evaluation demonstrated improved glycemic control and enhanced safety for insulin therapy.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Survey Safety
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Household Wiring And Electrical Safety


